Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288427425> ?p ?o ?g. }
- W4288427425 endingPage "5690" @default.
- W4288427425 startingPage "5678" @default.
- W4288427425 abstract "SARS-CoV-2 vaccines have contributed to the control of COVID-19 in some parts of the world. However, the constant emergence of variants of concern (VOCs) challenges the effectiveness of SARS-CoV-2 vaccines over time. In particular, Omicron contains a high number of mutations in the spike (S) protein gene, on which most vaccines were developed. In this study, we quantitated neutralizing antibodies in vaccine recipients at various times postvaccination using S protein-based pseudoviruses derived from wild type (WT) SARS-CoV-2 and five VOCs including Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2), and Omicron (B.1.1.529). We found that two-dose mRNA-1273 and BNT162b2 vaccines elicited robust neutralizing antibodies against WT, Alpha, Beta, Gamma, and Delta, but wanned after 6 months with a faster decline observed for BNT162b2. Both mRNA-1273 and BNT162b2 elicited weak neutralizing antibodies against Omicron. One dose of Ad26.COV2.S vaccine induced weaker neutralizing antibodies against WT and most VOCs than mRNA-1273 and BNT162b2 did but moderate neutralizing antibodies against Delta and Omicron, which lasted for 6 months. These results support current recommendations of the Centers for Disease Control and Prevention for a booster 5 months after full immunization with an mRNA-based vaccine and the use of an mRNA-based vaccine 2 months after Ad26.COV2.S vaccination." @default.
- W4288427425 created "2022-07-29" @default.
- W4288427425 creator A5008638025 @default.
- W4288427425 creator A5009004798 @default.
- W4288427425 creator A5010896860 @default.
- W4288427425 creator A5044364019 @default.
- W4288427425 creator A5045284378 @default.
- W4288427425 creator A5048400572 @default.
- W4288427425 creator A5055448380 @default.
- W4288427425 creator A5064238079 @default.
- W4288427425 creator A5068887242 @default.
- W4288427425 creator A5070051588 @default.
- W4288427425 creator A5071807929 @default.
- W4288427425 creator A5088001760 @default.
- W4288427425 date "2022-08-06" @default.
- W4288427425 modified "2023-10-03" @default.
- W4288427425 title "Neutralizing antibodies to SARS‐CoV‐2 variants of concern including Delta and Omicron in subjects receiving mRNA‐1273, BNT162b2, and Ad26.COV2.S vaccines" @default.
- W4288427425 cites W2121049053 @default.
- W4288427425 cites W2999318660 @default.
- W4288427425 cites W3004280078 @default.
- W4288427425 cites W3004348779 @default.
- W4288427425 cites W3022917947 @default.
- W4288427425 cites W3024355434 @default.
- W4288427425 cites W3024906457 @default.
- W4288427425 cites W3025553169 @default.
- W4288427425 cites W3034173374 @default.
- W4288427425 cites W3042950801 @default.
- W4288427425 cites W3043722389 @default.
- W4288427425 cites W3048827124 @default.
- W4288427425 cites W3090717270 @default.
- W4288427425 cites W3093367571 @default.
- W4288427425 cites W3093842248 @default.
- W4288427425 cites W3108043937 @default.
- W4288427425 cites W3108610942 @default.
- W4288427425 cites W3111255098 @default.
- W4288427425 cites W3116273806 @default.
- W4288427425 cites W3119345685 @default.
- W4288427425 cites W3121015296 @default.
- W4288427425 cites W3121365103 @default.
- W4288427425 cites W3131995220 @default.
- W4288427425 cites W3133532742 @default.
- W4288427425 cites W3134208712 @default.
- W4288427425 cites W3137142873 @default.
- W4288427425 cites W3141262235 @default.
- W4288427425 cites W3142246475 @default.
- W4288427425 cites W3153508314 @default.
- W4288427425 cites W3156343712 @default.
- W4288427425 cites W3159994714 @default.
- W4288427425 cites W3160471157 @default.
- W4288427425 cites W3165479483 @default.
- W4288427425 cites W3172296615 @default.
- W4288427425 cites W3172812363 @default.
- W4288427425 cites W3176239731 @default.
- W4288427425 cites W3177895433 @default.
- W4288427425 cites W3182094313 @default.
- W4288427425 cites W3183072827 @default.
- W4288427425 cites W3184513201 @default.
- W4288427425 cites W3184718675 @default.
- W4288427425 cites W3195069582 @default.
- W4288427425 cites W3198233589 @default.
- W4288427425 cites W3199227831 @default.
- W4288427425 cites W3199849883 @default.
- W4288427425 cites W3200511289 @default.
- W4288427425 cites W3213246152 @default.
- W4288427425 cites W3217746385 @default.
- W4288427425 cites W4200112411 @default.
- W4288427425 cites W4200230275 @default.
- W4288427425 cites W4200391585 @default.
- W4288427425 cites W4200469371 @default.
- W4288427425 cites W4200498553 @default.
- W4288427425 cites W4200505933 @default.
- W4288427425 cites W4200620504 @default.
- W4288427425 cites W4205240144 @default.
- W4288427425 cites W4205483821 @default.
- W4288427425 cites W4206040938 @default.
- W4288427425 cites W4206079892 @default.
- W4288427425 cites W4206481051 @default.
- W4288427425 cites W4206934653 @default.
- W4288427425 cites W4210362857 @default.
- W4288427425 cites W4210654369 @default.
- W4288427425 cites W4211043735 @default.
- W4288427425 cites W4211076340 @default.
- W4288427425 cites W4213143712 @default.
- W4288427425 cites W4213257347 @default.
- W4288427425 cites W4214483034 @default.
- W4288427425 cites W4220673385 @default.
- W4288427425 cites W4220689791 @default.
- W4288427425 cites W4220843256 @default.
- W4288427425 cites W4220887537 @default.
- W4288427425 cites W4221084154 @default.
- W4288427425 cites W4221094128 @default.
- W4288427425 cites W4223499046 @default.
- W4288427425 cites W4223609807 @default.
- W4288427425 cites W4223612665 @default.
- W4288427425 cites W4224922652 @default.
- W4288427425 cites W4225612109 @default.
- W4288427425 cites W4225691034 @default.
- W4288427425 cites W4225982774 @default.